Griseofulvin (Oceanside Pharmaceuticals)
Welcome to the PulseAid listing for the Griseofulvin drug offered from Oceanside Pharmaceuticals. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Oceanside Pharmaceuticals |
| NON-PROPRIETARY NAME: | Griseofulvin |
| SUBSTANCE NAME: | GRISEOFULVIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2016-07-26 |
| END MARKETING DATE: | 0000-00-00 |
Griseofulvin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Griseofulvin from Oceanside Pharmaceuticals |
| LABELER NAME: | Oceanside Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/1) |
| START MARKETING DATE: | 2016-07-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68682-519_ab5a4a1c-90f1-40f3-aab4-6f299a885c52 |
| PRODUCT NDC: | 68682-519 |
| APPLICATION NUMBER: | NDA050475 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers:
